国家基本药物政策能缓解“看病贵”吗?——基于2003～2010年省际数据实证分析  

The Effect of National Essential Medicine Policy on Medical Care Expenditure:Empirical Study Based on Provincial Panel Data during 2003～2010

作　　者：刘素坤[1] 王岭[2] 

机构地区：[1]东北财经大学产业组织与企业组织研究中心,辽宁大连116025 [2]浙江财经学院政府管制研究院,浙江杭州310018

出　　处：《经济问题》2013年第3期69-74,共6页On Economic Problems

摘　　要：利用2003～2010年31个省(市、自治区)的面板数据,采用双重差分模型,研究国家基本药物政策实施对门诊病人和住院病人医疗费用支出的影响。实证结果表明:国家基本药物政策不仅没有降低门诊病人和住院病人的医疗费用支出,反而促进了医疗费用支出增长。通过进一步的细分研究表明,国家医药政策对不同的患者群体、医疗费用类型和地区的影响程度存在差异。其中,国家基本药物政策对门诊病人医疗支出的影响大于对住院病人的影响;对病人药费支出的影响强于对医药费支出的影响,且对住院病人医药费支出影响不显著;在城市化水平低的地区的影响强于城市化水平高的地区。This paper quantitatively estimates the effect of National essential Medicine Policy on medical care expenditure with fixed effect panel data model using provincial panel data during 2003 - 2010 in China. The results of the article indicate that essential medicine policy did not inhibit outpatient and inpatient medical expenditure, but stimulus medical expenditure growth in the whole. The effect of National Essential medical policy on outpatient medical expenditures is more important than that on hospital patients. The impact on the patient medication expend- itures by National Essential medical policy is greater than the medical expenditure, and the impact on hospital pa- tients medical expenditure is not significant. The inhibiting effect of National Essential medical policy on health - care spending is better in the low level of urbanization areas than in the high level of urbanization areas.

关 键 词：基本药物政策 双重差分模型 政策有效性 医疗支出 

分 类 号：F113.9[经济管理—国际贸易]